The rate of dasotraline brain entry is slow following intravenous administration.
Rationale: Drugs that rapidly increase dopamine levels have an increased risk of abuse. Dasotraline (DAS) is a dopamine and norepinephrine reuptake inhibitor characterized by slow oral absorption with low potential for abuse. However, it remains unclear whether intravenous (i.v.) administration woul...
| Publicado en: | Psychopharmacology Vol. 237; no. 11; pp. 3435 - 3447 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |